Question 1 · Hard
CSF from a 20-year-old man with fever and a petechial rash shows gram-negative diplococci inside neutrophils. When the culture grows, a technologist makes a dense saline suspension of the colonies for latex agglutination and does oxidase and catalase tests on the open bench, without a biosafety cabinet. The isolate is oxidase positive, produces acid from glucose and maltose but not from lactose or sucrose, and is confirmed as Neisseria meningitidis serogroup W. The technologist is well and received a MenACWY vaccine 6 years ago. What is the most appropriate action for the technologist?
- ANo action, as the vaccine protects fully
- BOffer antibiotic chemoprophylaxis now
- CGive a MenACWY booster as the only step
- DTake a throat swab; treat only if positive
Show answerHide answer
Answer: B · Offer antibiotic chemoprophylaxis now
The Gram stain and the glucose and maltose reactions identify N. meningitidis, and making dense suspensions and doing tests outside a cabinet can expose the worker to droplets and aerosols. Laboratory-acquired meningococcal disease is rare but often fatal, so an exposed laboratorian should be offered chemoprophylaxis (for example ciprofloxacin, rifampin or ceftriaxone) without delay. Vaccination does not remove this need, because protection wanes over time and vaccines do not cover every serogroup. A throat culture is insensitive and waiting for it delays protection, and a booster alone acts too slowly. Work with suspected meningococcal isolates belongs in a class II biosafety cabinet.
- A: Protection from a vaccine given 6 years ago wanes, and vaccination does not replace prophylaxis.
- C: A booster takes days to act and does not replace prophylaxis after an exposure.
- D: A throat culture is insensitive, and waiting for it delays protection.